吉非替尼敏感型小细胞肺癌中的表皮生长因子受体（EGFR）突变 - Suppr

Suppr

超能文献

EGFR mutation in gefitinib-responsive small-cell lung cancer.

作者信息

Okamoto I, Araki J, Suto R, Shimada M, Nakagawa K, Fukuoka M

出版信息

Ann Oncol. 2006 Jun;17(6):1028-9. doi: 10.1093/annonc/mdj114. Epub 2005 Dec 15.

DOI:10.1093/annonc/mdj114

PMID:16357019

Abstract

摘要

相似文献

EGFR mutation in gefitinib-responsive small-cell lung cancer.吉非替尼敏感型小细胞肺癌中的表皮生长因子受体（EGFR）突变

Ann Oncol. 2006 Jun;17(6):1028-9. doi: 10.1093/annonc/mdj114. Epub 2005 Dec 15.

EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.表皮生长因子受体（EGFR）突变L747P导致一名中国肺腺癌患者对吉非替尼产生耐药，并加速了肝转移。

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8603-6. eCollection 2015.

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer.表皮生长因子受体（EGFR）突变及其与吉非替尼对既往接受治疗的中国晚期非小细胞肺癌患者疗效的相关性。

Ann Oncol. 2005 Aug;16(8):1334-42. doi: 10.1093/annonc/mdi340. Epub 2005 Jun 14.

Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations.物理尺寸对携带 EGFR 突变的非小细胞肺癌患者吉非替尼疗效的影响。

Lung Cancer. 2013 Sep;81(3):435-439. doi: 10.1016/j.lungcan.2013.05.021. Epub 2013 Jul 1.

Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.从未吸烟的肺腺癌患者使用吉非替尼治疗后发生伴有表皮生长因子受体突变的小细胞癌。

Clin Lung Cancer. 2010 Sep 1;11(5):E1-4. doi: 10.3816/CLC.2010.n.046.

Clinical development of gefitinib in non-small-cell lung cancer and the Iressa Survival Evaluation in Lung Cancer trial.吉非替尼在非小细胞肺癌中的临床开发及肺癌易瑞沙生存评估试验

Clin Lung Cancer. 2005 Jan;6(4):214-6. doi: 10.1016/s1525-7304(11)70473-9.

Mutations in the epidermal growth factor receptor tyrosine kinase may predict response to gefitinib in non-small-cell lung cancer.表皮生长因子受体酪氨酸激酶的突变可能预测非小细胞肺癌对吉非替尼的反应。

Clin Lung Cancer. 2004 May;5(6):331-2. doi: 10.1016/s1525-7304(11)70182-6.

EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer.吉非替尼治疗的初治非小细胞肺癌患者肿瘤及血清中的表皮生长因子受体（EGFR）突变

J Thorac Oncol. 2006 Mar;1(3):260-7. doi: 10.1016/s1556-0864(15)31577-x.

Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?非小细胞肺癌分子靶向维持治疗的时机到了吗？

Lancet Oncol. 2010 Jun;11(6):500-1. doi: 10.1016/S1470-2045(10)70120-0. Epub 2010 May 20.

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow.表皮生长因子受体抑制剂的预测因素——靶心命中箭头。

Cancer Cell. 2004 May;5(5):411-5. doi: 10.1016/s1535-6108(04)00122-9.

引用本文的文献

Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications.神经内分泌转化作为肺癌靶向治疗耐药的一种机制：新出现的机制及其治疗意义

Cancers (Basel). 2025 Jan 15;17(2):260. doi: 10.3390/cancers17020260.

Clinical features and prognostic factors of IV combined small cell lung cancer: A propensity score matching analysis.IV 期小细胞肺癌的临床特征和预后因素：倾向评分匹配分析。

PLoS One. 2024 Nov 8;19(11):e0313221. doi: 10.1371/journal.pone.0313221. eCollection 2024.

Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study.探索不同组织学类型的小细胞肺癌治疗策略差异及局限期小细胞肺癌预后因素的预后影响：一项基于监测、流行病学和最终结果（SEER）数据库人群的研究

Heliyon. 2024 Jun 19;10(12):e32907. doi: 10.1016/j.heliyon.2024.e32907. eCollection 2024 Jun 30.

Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study.剖析小细胞肺癌患者一线化疗反应相关的基因变异：一项回顾性队列研究。

J Thorac Dis. 2023 Dec 30;15(12):7013-7023. doi: 10.21037/jtd-23-1772. Epub 2023 Dec 26.

Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.小细胞肺癌全景中的分子和遗传进展：从同质性到多样性。

Int J Mol Sci. 2023 Dec 22;25(1):224. doi: 10.3390/ijms25010224.

A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients.小细胞肺癌患者中罕见的表皮生长因子受体（EGFR）基因突变。

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Sep;166(3):274-279. doi: 10.5507/bp.2022.007. Epub 2022 Feb 18.

Molecular genetic profiling of small cell lung carcinoma in a Chinese cohort.中国人群中小细胞肺癌的分子遗传图谱分析

Transl Cancer Res. 2019 Feb;8(1):255-261. doi: 10.21037/tcr.2019.01.26.

A Rare Case of Small Cell Lung Cancer With an Epidermal Growth Factor Receptor Mutation and Its Response to Osimertinib.1例伴有表皮生长因子受体突变的小细胞肺癌及其对奥希替尼的反应的罕见病例

Cureus. 2021 May 20;13(5):e15136. doi: 10.7759/cureus.15136.

Extensive-Stage Small Cell Carcinoma Transformation From EGFR Del19-Mutant Lung Adenocarcinoma on Gefitinib at the Twelfth-Year Follow-Up Case Report.吉非替尼治疗12年随访时EGFR Del19突变型肺腺癌转化为广泛期小细胞癌病例报告

Front Oncol. 2021 Mar 18;11:564799. doi: 10.3389/fonc.2021.564799. eCollection 2021.

Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report.携带EGFR 19号外显子缺失突变的小细胞肺癌对化疗和EGFR-TKI均耐药：一例报告

Front Oncol. 2020 Jul 17;10:1048. doi: 10.3389/fonc.2020.01048. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验